Michael Tomsicek
Vermögen: 36 287 $ am 31.05.2026
Vermögen: 36 287 $ am 31.05.2026
Herr Michael J. Tomsicek ist ein unabhängiger Non-Executive Director bei Milestone Pharmaceuticals, Inc. und ein CFO & Principal Accounting Officer bei CRISPR Therapeutics AG. Er ist Mitglied des Board of Directors bei Milestone Pharmaceuticals, Inc. und Optimer Pharmaceuticals LLC. Herr Tomsicek war zuvor als CFO, Treasurer, Principal Accounting Officer & VP bei ABIOMED, Inc. beschäftigt, als Treasurer bei Cubist Pharmaceuticals, Inc, als CFO-Global Ultrasound Product Group bei General Electric Healthcare Technologies, Inc, als Manager-Commercial Finance & Business Planning bei Motorola Automotive & Industrial Electronics Group und als Chief Financial Officer bei The Lexington. Er war auch im Vorstand von Trius Therapeutics, Inc. Er erhielt seinen Bachelor-Abschluss von der University of Wisconsin und einen MBA von der University of Wisconsin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 15’001 ( 0.01% ) | 21 301 $ | 31.05.2026 | |
| 17.06.2026 | 9’366 ( 0.02% ) | 14 986 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 01.04.2019 |
| ACRIVON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.10.2022 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Direktor/Vorstandsmitglied | 24.10.2013 |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Direktor/Vorstandsmitglied | 03.11.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| CRISPR THERAPEUTICS AG | Finanzdirektor/CFO | 14.10.2021 |
| ABIOMED, INC. | Finanzdirektor/CFO | 24.08.2017 |
| CUBIST PHARMACEUTICALS INC | Finanzdirektor/CFO | 01.01.2015 |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Corporate Officer/Principal | 01.09.2010 |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Health Services |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Health Services |
Motorola Automotive & Industrial Electronics Group | |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen